Themis Medicare Ltd
NSE:THEMISMED

Watchlist Manager
Themis Medicare Ltd Logo
Themis Medicare Ltd
NSE:THEMISMED
Watchlist
Price: 95.42 INR 0.34%
Market Cap: 8.8B INR

Intrinsic Value

The intrinsic value of one THEMISMED stock under the Base Case scenario is 77.82 INR. Compared to the current market price of 95.42 INR, Themis Medicare Ltd is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

THEMISMED Intrinsic Value
77.82 INR
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Themis Medicare Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about THEMISMED?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is THEMISMED valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Themis Medicare Ltd.

Explain Valuation
Compare THEMISMED to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about THEMISMED?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Themis Medicare Ltd

Current Assets 3B
Cash & Short-Term Investments 189.6m
Receivables 1.7B
Other Current Assets 1.1B
Non-Current Assets 2.8B
Long-Term Investments 976.3m
PP&E 1.7B
Intangibles 2.2m
Other Non-Current Assets 135.6m
Current Liabilities 1.7B
Accounts Payable 467.5m
Other Current Liabilities 1.3B
Non-Current Liabilities 285.7m
Long-Term Debt 176.1m
Other Non-Current Liabilities 109.6m
Efficiency

Free Cash Flow Analysis
Themis Medicare Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Themis Medicare Ltd

Revenue
3.4B INR
Cost of Revenue
-1.3B INR
Gross Profit
2.2B INR
Operating Expenses
-2.4B INR
Operating Income
-206.2m INR
Other Expenses
-63.6m INR
Net Income
-269.8m INR
Fundamental Scores

THEMISMED Profitability Score
Profitability Due Diligence

Themis Medicare Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROE
Sustainable 3Y Average Operating Margin
39/100
Profitability
Score

Themis Medicare Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

THEMISMED Solvency Score
Solvency Due Diligence

Themis Medicare Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
61/100
Solvency
Score

Themis Medicare Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

THEMISMED Price Targets Summary
Themis Medicare Ltd

There are no price targets for THEMISMED.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for THEMISMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one THEMISMED stock?

The intrinsic value of one THEMISMED stock under the Base Case scenario is 77.82 INR.

Is THEMISMED stock undervalued or overvalued?

Compared to the current market price of 95.42 INR, Themis Medicare Ltd is Overvalued by 18%.

Back to Top